Molecular Imaging Corporation, formerly known as Mobile PET Systems, Inc., announced that it has secured a US$3.2 million asset-based finance facility provided by Meridian Commercial Healthcare Finance, LLC. The company intends to use available funds under the facility for potential Positron Emission Tomography (PET) imaging centre acquisitions and for additional working capital.
In a separate transaction, the Company entered into an agreement with Ascendiant Capital Group, LLC and its affiliate, Ascendiant PET Partners to refinance certain equipment leases assigned to Ascendiant, for approximately US$3.4 million, through the modification of the terms of the equipment leases.
"The credit facilities provided by Ascendiant and Meridian will help drive the company's growth, " said Paul J. Crowe, Chief Executive Officer of Molecular Imaging Corporation.
